First-line FOLFOX plus panitumumab (Pan) followed by 5FU/LV plus Pan or single-agent Pan as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): The VALENTINO study.-Reference-Cited by-同舟云学术

First-line FOLFOX plus panitumumab (Pan) followed by 5FU/LV plus Pan or single-agent Pan as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): The VALENTINO study.

Published:2018-05-20 Issue:15_suppl Volume:36 Page:3505-3505
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Pietrantonio Filippo¹,Morano Federica¹,Corallo Salvatore²,Lonardi Sara³,Cremolini Chiara⁴,Rimassa Lorenza⁵,Sartore-Bianchi Andrea⁶,Tampellini Marco⁷,Bustreo Sara⁸,Clavarezza Matteo⁹,Murialdo Roberto¹⁰,Zaniboni Alberto¹¹,Adamo Vincenzo¹²,Tomasello Gianluca¹³,Giordano Monica¹⁴,Petrelli Fausto¹⁵,Longarini Raffaella¹⁶,Zagonel Vittorina¹⁷,Di Bartolomeo Maria¹⁸,De Braud Filippo G.¹⁹

Affiliation:

1. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;

2. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;

3. Istituto Oncologico Veneto-IRCCS, Padova, Italy;

4. Pisa University Hospital, Tuscan Tumor Institute, Pisa, Italy;

5. Humanitas Clinical and Research Center, Rozzano, Italy;

6. Grande Ospedale Metropolitano Niguarda, Milan, Italy;

7. Oncologia Medica Aso San Luigi, San Martino Canavese, Italy;

8. Dipartimento di Oncologia- SSD ColoRectal Cancer Unit- AOU Città della Salute e della Scienza di Torino, Turin, Italy;

9. Division of Medical Oncology, E.O. Galliera Hospital, Genoa, Italy;

10. A.O.S. MARTINO, Genoa, Italy;

11. Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy;

12. Medical Oncology Unit-A.O. Papardo, Messina and Department of Human Pathology University of Messina, Messina, Italy;

13. ASST di Cremona – Ospedale di Cremona, Cremona, Italy;

14. Santa Anna Hospital, Como, Italy;

15. ASST Bergamo Ovest, Treviglio, Italy;

16. Oncologia Medica H S.Gerardo, Monza, Italy;

17. Department of Clinical and Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy;

18. Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy;

19. Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2018.36.15_suppl.3505

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212);International Journal of Cancer;2023-10-15

2. microRNAs in Liquid Biopsy: The Way to a Simple and Rapid Test for Early Colorectal Cancer Diagnosis?;Cancers;2023-01-28

3. Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer;Journal of Cancer Policy;2022-09

4. The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer;Future Oncology;2022-08

5. Management of Metastatic Colorectal Carcinoma in Older Adults: Balancing Risks and Benefits of Novel Therapies;Drugs & Aging;2021-06-18